These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 23906767
1. The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamine. Xu SX, Zhou ZQ, Li XM, Ji MH, Zhang GF, Yang JJ. Behav Brain Res; 2013 Sep 15; 253():305-9. PubMed ID: 23906767 [Abstract] [Full Text] [Related]
2. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Wang X, Yang Y, Zhou X, Wu J, Li J, Jiang X, Qu Q, Ou C, Liu L, Zhou S. Psychiatry Res; 2011 Jan 30; 185(1-2):248-53. PubMed ID: 20580983 [Abstract] [Full Text] [Related]
3. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Eur Psychiatry; 2014 Sep 30; 29(7):419-23. PubMed ID: 24321772 [Abstract] [Full Text] [Related]
4. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J. Behav Brain Res; 2011 Aug 01; 221(1):166-71. PubMed ID: 21397634 [Abstract] [Full Text] [Related]
6. Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression. Odaira T, Nakagawasai O, Takahashi K, Nemoto W, Sakuma W, Lin JR, Tan-No K. Neuropharmacology; 2019 May 15; 150():121-133. PubMed ID: 30914305 [Abstract] [Full Text] [Related]
7. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J. Basic Clin Pharmacol Toxicol; 2008 Dec 15; 103(6):502-6. PubMed ID: 19067677 [Abstract] [Full Text] [Related]
8. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E. Neuropharmacology; 2012 Jan 15; 62(1):391-7. PubMed ID: 21867718 [Abstract] [Full Text] [Related]
9. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. Li HL, Yin R, Chen D, Liu D, Wang D, Yang Q, Dong YG. J Cell Biochem; 2007 Apr 01; 100(5):1086-99. PubMed ID: 17266062 [Abstract] [Full Text] [Related]
10. Tramadol reinforces antidepressant effects of ketamine with increased levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in rat hippocampus. Yang C, Li X, Wang N, Xu S, Yang J, Zhou Z. Front Med; 2012 Dec 01; 6(4):411-5. PubMed ID: 23124884 [Abstract] [Full Text] [Related]
11. Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice. Jang S, Kim H, Jeong J, Lee SK, Kim EW, Park M, Kim CH, Lee JE, Namkoong K, Kim E. Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov 03; 71():57-65. PubMed ID: 27343360 [Abstract] [Full Text] [Related]
12. MAPK signaling correlates with the antidepressant effects of ketamine. Réus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, Carlessi AS, Neotti MV, Matias BI, Luz JR, Dal-Pizzol F, Quevedo J. J Psychiatr Res; 2014 Aug 03; 55():15-21. PubMed ID: 24819632 [Abstract] [Full Text] [Related]
13. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B, Zhang JC, Han M, Yao W, Yang C, Ren Q, Ma M, Chen QX, Hashimoto K. Psychopharmacology (Berl); 2016 Oct 03; 233(19-20):3647-57. PubMed ID: 27488193 [Abstract] [Full Text] [Related]
14. Chronic stress-induced memory deficits are reversed by regular exercise via AMPK-mediated BDNF induction. Kim DM, Leem YH. Neuroscience; 2016 Jun 02; 324():271-85. PubMed ID: 26975895 [Abstract] [Full Text] [Related]
15. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K. Psychopharmacology (Berl); 2015 Dec 02; 232(23):4325-35. PubMed ID: 26337614 [Abstract] [Full Text] [Related]
16. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Meng R, Pei Z, Zhang A, Zhou Y, Cai X, Chen B, Liu G, Mai W, Wei J, Dong Y. Arch Biochem Biophys; 2011 Jul 02; 511(1-2):1-7. PubMed ID: 21530483 [Abstract] [Full Text] [Related]
17. The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate. Xie Y, Huang X, Hu SY, Zhang YJ, Wang Y, Qiu XJ, Ren P, Fan R, Zhang CH, Xie WB, Ji H, He J, Chen X, Xie L, Liu ZQ, Zhou HH. Amino Acids; 2013 Feb 02; 44(2):413-22. PubMed ID: 22782214 [Abstract] [Full Text] [Related]
18. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms. Wei IH, Chen KT, Tsai MH, Wu CH, Lane HY, Huang CC. J Agric Food Chem; 2017 Dec 13; 65(49):10792-10803. PubMed ID: 29161812 [Abstract] [Full Text] [Related]
19. Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Yang C, Hu YM, Zhou ZQ, Zhang GF, Yang JJ. Ups J Med Sci; 2013 Mar 13; 118(1):3-8. PubMed ID: 22970723 [Abstract] [Full Text] [Related]
20. Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Franco JL, Posser T, Brocardo PS, Trevisan R, Uliano-Silva M, Gabilan NH, Santos AR, Leal RB, Rodrigues AL, Farina M, Dafre AL. Behav Brain Res; 2008 Apr 09; 188(2):316-23. PubMed ID: 18191237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]